Anticancer activity of andrographolide semisynthetic derivatives

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Oncology

Background:

• Andrographolide 1, a natural compound from Andrographis paniculata, exhibits antitumor effects.
• Existing research shows andrographolide's efficacy in breast cancer and leukemia models.
• There is a need for novel therapeutic agents against non-small cell lung cancer (NSCLC).

Purpose of the Study:

• To semi-synthesize novel andrographolide derivatives.
• To evaluate the in vitro cytotoxic activity of these derivatives against the A549 NSCLC cell line.

Main Methods:

• Semi-synthesis of andrographolide derivatives.
• In vitro cytotoxicity assays using the A549 (ATCC) cell line.
• Determination of half-maximal inhibitory concentration (IC50) values.

Main Results:

• Several andrographolide derivatives were successfully synthesized.
• Compounds 3-5 demonstrated potent in vitro activity against A549 cells.
• IC50 values for compounds 3-5 ranged from 22-31 microg/mL.

Conclusions:

• The synthesized andrographolide derivatives possess significant cytotoxic activity against NSCLC cells.
• Compounds 3-5 are promising candidates for further investigation as potential anti-NSCLC agents.
• This study highlights the therapeutic potential of modified andrographolide structures in cancer treatment.